Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

novartis europharm limited - inclisiran - hypercholesterolemia; dyslipidemias - lipid modifying agents - leqvio is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin, oralone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - clotrimazole, quantity: 1 % w/w; hydrocortisone acetate, quantity: 1 % w/w - cream - excipient ingredients: light liquid paraffin; purified water; propylene glycol; ceteareth-20; cetostearyl alcohol - broad spectrum anti-fungal and anti-inflammatory cream for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as tinea (athlete's foot, jock itch, ring worm), fungal skin rash, thrush infections of the skin, fungally infected nappy rash and eczema/dermatitis.

Canada - Tiếng Anh - Health Canada

eli lilly canada inc - raloxifene hydrochloride - tablet - 60mg - raloxifene hydrochloride 60mg - estrogen agonist-antagonists

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

vistapharm, inc. - methadone hydrochloride (unii: 229809935b) (methadone - unii:uc6vbe7v1z) - methadone hydrochloride 10 mg - methadone hydrochloride tablets are indicated for the: limitations of use methadone products used for the treatment of opioid addiction in detoxification or maintenance programs are subject to the conditions for distribution and use required under 42 cfr 8.12 [see dosage and administration (2.1)] . methadone hydrochloride tablets are contraindicated in patients with: hypersensitivity (e.g., anaphylaxis) to methadone [see adverse reactions (6)] . risk summary neonatal opioid withdrawal syndrome (nows) is an expected and treatable outcome of prolonged use of opioids during pregnancy [see warnings and precautions (5.4 )] . pregnant women in methadone maintenance programs may have reduced incidence of obstetric and fetal complications and neonatal morbidity and mortality when compared to women using illicit drugs. untreated opioid addiction in pregnancy is associated with adverse obstetrical outcomes and risk of continued or relapsing illicit opioid use. these risks should be considered in women treated with meth

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

vistapharm, llc - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml - levetiracetam oral solution is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. levetiracetam oral solution is indicated as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution is indicated as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy. levetiracetam oral solution is contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), including levetiracetam, during pregnancy. encourage women who are taking levetiracetam during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

daiichi sankyo uk ltd - raloxifene hydrochloride - tablet - 60mg

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - benzydamine hydrochloride, quantity: 3 mg/ml - spray, solution - excipient ingredients: saccharin sodium; ethanol; purified water; peg-40 hydrogenated castor oil; mint oil dementholised; methyl hydroxybenzoate; glycerol - anti-inflammatory throat spray for the temporary relief of painful conditions of the oral cavity including tonsillitis, sore throat, radiation mucositis, aphthous ulcers, pharyngitis, swelling, post-surgical oral and periodontal procedures, redness and inflammatory conditions.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

nova pharmaceuticals australasia pty ltd - benzydamine hydrochloride, quantity: 1.5 mg/ml - spray, solution - excipient ingredients: purified water; mint oil dementholised; glycerol; ethanol; methyl hydroxybenzoate; saccharin sodium; peg-40 hydrogenated castor oil - anti-inflammatory throat spray for the temporary relief of painful conditions of the oral cavity including tonsillitis, sore throat, radiation mucositis, aphthous ulcers, pharyngitis, swelling, post-surgical oral and periodontal procedures, redness and inflammatory conditions.

Nam Phi - Tiếng Anh - South African Health Products Regulatory Authority (SAHPRA)

eli lilly (s.a.) (pty) ltd - tablet - see ingredients - each tablet contains raloxifene hydrochloride 60,0 mg

Philippin - Tiếng Anh - FDA (Food And Drug Administration)

vista pharma, inc.; importer: n/a; distributor: n/a - aciclovir - ointment - 30 mg/g (3% w/w) ophthalmic